Systematic review and feasibility study on pre-analytical factors and genomic analyses on archival formalin-fixed paraffin-embedded breast cancer tissue von Salgkamis, Dimitrios, Sifakis, Emmanouil G., Agartz, Susanne, Wirta, Valtteri, Hartman, Johan, Bergh, Jonas, Foukakis, Theodoros, Matikas, Alexios, Zerdes, Ioannis

Volltext

Unveiling the Power of Model-Agnostic Multiscale Analysis for Enhancing Artificial Intelligence Models in Breast Cancer Histopathology Images von Tsiknakis, Nikos, Manikis, Georgios, Tzoras, Evangelos, Salgkamis, Dimitrios, Vidal, Joan Martinez, Wang, Kang, Zaridis, Dimitris, Sifakis, Emmanouil, Zerdes, Ioannis, Bergh, Jonas, Hartman, Johan, Acs, Balazs, Marias, Kostas, Foukakis, Theodoros

Volltext

Multiomic profiling reveals predictive molecular characteristics of response to neoadjuvant antibody-drug conjugate versus chemotherapy and dual HER2 blockade in HER2 positive brea... von Foukakis, T., Wang, K., Zerdes, I., Zhu, Y., Sifakis, E., Tsiknakis, N., Manikis, G., Salgkamis, D., Harbers, L., Bergh, J., Johansson, H., Crosetto, N., Lehtiö, J., Matikas, A., Hatschek, T.

Volltext

Interplay between copy number alterations and immune profiles in the early breast cancer Scandinavian Breast Group 2004-1 randomized phase II trial: results from a feasibility stud... von Zerdes, Ioannis, Simonetti, Michele, Matikas, Alexios, Harbers, Luuk, Acs, Balazs, Boyaci, Ceren, Zhang, Ning, Salgkamis, Dimitrios, Agartz, Susanne, Moreno-Ruiz, Pablo, Bai, Yalai, Rimm, David L., Hartman, Johan, Mezheyeuski, Artur, Bergh, Jonas, Crosetto, Nicola, Foukakis, Theodoros

Volltext

69P Deep learning prognostication through prediction of TP53 gene mutation status on breast cancer hematoxylin and eosin slides von Tsiknakis, N., Salgkamis, D., Tzoras, E., Wang, K., Liu, X., Manikis, G., Sifakis, E.G., Bergh, J., Marias, K., Zerdes, I., Matikas, A., Foukakis, T.

Volltext

56P Longitudinal circulating plasma protein immune profiling reveals biomarkers of treatment response to neoadjuvant trastuzumab-emtansine (T-DM1) in early HER2-positive breast can... von Zerdes, I., Wang, K., Salgkamis, D., Zhu, Y., Sifakis, E.G., Acs, B., Hartman, J., Hatschek, T., Bergh, J., Matikas, A., Foukakis, T.

Volltext

Longitudinal tumor-immune microenvironment changes in patients with clinical luminal A early breast cancer treated with neoadjuvant palbociclib and endocrine therapy: results from... von Zerdes, I, Salgkamis, D, Matikas, A, Selander, L, Wang, K, Tzoras, E, Sifakis, E, Agartz, S, Chen, XS, Hellstrom, M, Hartman, J, Bergh, J, Foukakis, T, Hatschek, T

Volltext

Correlative and longitudinal transcriptomic profiling predicts patient outcomes and the efficacy of neoadjuvant HER2-targeted treatments in the randomized PREDIX HER2 trial von Wang, K, Zhu, YJ, Zerdes, I, Matikas, A, Sifakis, E, Salgkamis, D, Bjohle, J, Elinder, E, Margolin, S, Campos, AB, Pekar, G, Lindman, H, Schiza, A, Einbeigi, Z, Adra, J, Andersson, A, Carlsson, L, Dreifaldt, AC, Isaksson-Friman, E, Agartz, S, Johansson, H, Hellstrom, M, Azavedo, E, Hartman, J, Bergh, J, Hatschek, T, Foukakis, T

Volltext

Integrated immuno-genomic analyses in early breast cancer: Results from the Scandinavian breast group 2004-1 (SBG-2004-1) randomized phase II trial von Zerdes, I, Simonetti, M, Matikas, A, Harbers, L, Zhang, N, Salgkamis, D, Agartz, S, Zacharouli, M, Moreno-Ruiz, P, Hartman, J, Mezheyeuski, A, Bergh, J, Crosetto, N, Foukakis, T

Volltext